ENHO antisense RNA 1 (ENHO-AS1)

ENHO antisense RNA 1 (ENHO-AS1) appears to be the name of an antisense RNA presumed to be transcribed opposite the ENHO gene locus. However, as of September 2025, there is no evidence in major databases (such as NCBI, Ensembl, or lncRNA catalogues) or recent literature to support that "ENHO antisense RNA 1" is a defined or characterized entity. Antisense RNAs generally are long non-coding RNAs (lncRNAs) involved in complementary hybridization with sense transcripts, potentially regulating gene expression via transcriptional interference, epigenetic modification, or splicing regulation[1]. They may participate in either positive or negative gene regulation, but "ENHO-AS1" specifically does not appear as a known, validated lncRNA or therapeutic target in the scientific record. Thus, it is not currently recognized as a gene, transcript, or pharmacological target. Key reasons for classification: - There is no evidence of a canonical or functionally validated RNA called "ENHO antisense RNA 1." - The naming matches conventions for antisense long non-coding RNAs but does not correspond to an established biological entity. - No disease association, drug targeting, or biomarker use for ENHO-AS1 is found in the literature or major reference sources. If you intended a closely related or similarly named target, please provide a synonym or more context for clarification. If you are exploring antisense RNAs generically, they are a broad class of gene regulatory lncRNAs with potential—but not all annotated antisense transcripts are characterized or druggable targets[1].